Skip to main content
Premium Trial:

Request an Annual Quote

Pfizer Extends License to Gene Logic s ToxExpress Database

NEW YORK, Oct. 4 - Gene Logic of Gaithersburg, Md., said Thursday that Pfizer had extended it subscription to Gene Logic's ToxExpress database module. 

Pfizer, which has had access to ToxExpress since 2000, extended its total subscription term to five years. 

Gene Logic did not disclose financial terms of the deal. 

In January, Gene logic and Pfizer announced an agreement to jointly develop a microarray for toxicology studies using Affymetrix’s GeneChip technology.

Under the agreement, Gene Logic and Pfizer researchers said they would design the array, while Affymetrix would build it. The array will only be available to subscribers of Gene Logic’s ToxExpress and is designed to complement the ToxExpress’s library of toxicity markers.   

ToxExpress is a module in the GeneExpress suite of databases. It offers data on the effects of more than 10 toxic compounds on the liver, kidney, bone marrow, and heart of animals.

 

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.